Cargando…
Possible Role of Interleukin-1β in Type 2 Diabetes Onset and Implications for Anti-inflammatory Therapy Strategies
Increasing evidence of a role of chronic inflammation in type 2 diabetes progression has led to the development of therapies targeting the immune system. We develop a model of interleukin-1β dynamics in order to explain principles of disease onset. The parameters in the model are derived from in vit...
Autores principales: | Zhao, Gang, Dharmadhikari, Gitanjali, Maedler, Kathrin, Meyer-Hermann, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4148195/ https://www.ncbi.nlm.nih.gov/pubmed/25167060 http://dx.doi.org/10.1371/journal.pcbi.1003798 |
Ejemplares similares
-
Siglec-7 restores β-cell function and survival and reduces inflammation in pancreatic islets from patients with diabetes
por: Dharmadhikari, Gitanjali, et al.
Publicado: (2017) -
Evaluation of Existing Methods for Human Blood mRNA Isolation and Analysis for Large Studies
por: Meyer, Anke, et al.
Publicado: (2016) -
MST1 deletion protects β-cells in a mouse model of diabetes
por: Ardestani, Amin, et al.
Publicado: (2022) -
Neratinib is an MST1 inhibitor and restores pancreatic β-cells in diabetes
por: Ardestani, Amin, et al.
Publicado: (2019) -
mTORC in β cells: more Than Only Recognizing Comestibles
por: Maedler, Kathrin, et al.
Publicado: (2017)